ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

NCI Grant Funding Payline To Begin At 16th Percentile In FY 2010

December 11, 2009

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

Federal Budget Cuts Implemented March 1; HHS Agencies Grapple with Consequences

March 8, 2013